Concepts (32)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 2 | 2015 | 42 | 0.970 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2015 | 4 | 0.500 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2015 | 5 | 0.500 |
Why?
|
Blood Cells | 1 | 2015 | 4 | 0.500 |
Why?
|
Vascular Remodeling | 1 | 2015 | 4 | 0.500 |
Why?
|
Vascular System Injuries | 1 | 2015 | 4 | 0.500 |
Why?
|
Coronary Restenosis | 1 | 2015 | 10 | 0.500 |
Why?
|
Drug-Eluting Stents | 1 | 2015 | 14 | 0.490 |
Why?
|
Atherosclerosis | 1 | 2015 | 49 | 0.470 |
Why?
|
Wound Healing | 2 | 2015 | 149 | 0.220 |
Why?
|
Animals | 4 | 2015 | 3391 | 0.180 |
Why?
|
Mice, Knockout | 2 | 2015 | 264 | 0.140 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 370 | 0.140 |
Why?
|
Mice | 3 | 2015 | 1282 | 0.140 |
Why?
|
Type III Secretion Systems | 1 | 2015 | 1 | 0.130 |
Why?
|
Diabetic Foot | 1 | 2015 | 3 | 0.130 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 19 | 0.130 |
Why?
|
Wound Infection | 1 | 2015 | 7 | 0.130 |
Why?
|
Pseudomonas Infections | 1 | 2015 | 47 | 0.120 |
Why?
|
Pseudomonas aeruginosa | 1 | 2015 | 59 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 318 | 0.120 |
Why?
|
Chemokine CCL2 | 1 | 2014 | 17 | 0.110 |
Why?
|
Cells, Cultured | 1 | 2015 | 474 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2014 | 56 | 0.110 |
Why?
|
Rats | 1 | 2015 | 596 | 0.110 |
Why?
|
Macrophages | 1 | 2014 | 105 | 0.110 |
Why?
|
Male | 2 | 2015 | 14124 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2015 | 570 | 0.050 |
Why?
|
Virulence | 1 | 2015 | 10 | 0.030 |
Why?
|
Biofilms | 1 | 2015 | 14 | 0.030 |
Why?
|
Skin | 1 | 2014 | 103 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 171 | 0.020 |
Why?
|